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Abstract  
 Mutations in the Retinoblastoma (RB) tumor suppressor gene or disruptions in the 
RB-E2F signaling pathway have been identified in most human cancers. Homozygous 
deletion of Rb (Rb-/-) in mice causes embryonic lethality by day 15.5 of gestation. 
Lethality of Rb ablation is not due to an intrinsic function of Rb in the fetus, but rather 
due to the severe disruption of placental architecture and function (Wu et. al, 2003). In 
the present study, we show that additional Rb function in maternal tissues other than the 
placenta is critical for fetal viability. Loss of one allele of Rb (Rb+/-) in the mother 
resulted in increased fetal mortality upon exposure to the synthetic steroid 
dexamethasone during pregnancy. Liver-specific deletion of one or both conditional Rb 
alleles in mothers exposed to dexamethasone also resulted in fetal mortality, suggesting 
that the liver is an important site of pregnancy-associated Rb function. This study reveals 
a non-classical role for Rb in the detoxification of harmful substances and preservation of 
embryonic development during pregnancy. 
  
Introduction: 
Review of literature 
Mutations in the Retinoblastoma (RB) tumor suppressor gene or disruptions in the RB-
E2F signaling pathway have been identified in most human cancers (Harbour and Dean, 
2007). Furthermore, studies in mice have shown that Rb is essential for embryonic 
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development (Jacks et. al, 1992). Rb mutant (Rb-/-) embryos exhibit ectopic proliferation 
and apoptosis in the central nervous system (CNS) and have defective erythropoiesis, 
leading to lethality by embryonic day 15.5 (E15.5) (Jacks et. al, 1992, Lee et. al, 1992, 
Clarke et. al, 1992; Wu et. al, 2003). Loss of Rb specifically in the placenta severely 
disrupts the labyrinth architecture by inducing unscheduled proliferation of trophoblast 
cells (Wenzel et. al, 2007; de Bruin et. al, 2003). This leads to compromised placental 
vascularization and reduced placental surface area, which impair the exchange of waste 
and nutrients between mother and fetus, also resulting in lethality by E15.5 (Wenzel et. 
al, 2007; de Bruin et. al, 2003). Consistent with cell non-autonomous functions for Rb in 
maintaining fetal viability, Rb-deficient embryos supplied with a wild-type placenta did 
not exhibit the above neurologic and erythroid abnormalities thought to cause their 
demise. These embryos could be carried to term but die shortly after birth due to 
muscular and skeletal abnormalities (de Bruin et. al, 2003; Wu et. al, 2003).   
Retinoblastoma is a childhood retinal cancer caused by mutation of the RB tumor 
suppressor gene and accounts for more than three percent of all cancers diagnosed under 
the age of 15. RB is widely known to control cell cycle progression by binding the E2F 
family of transcription factors, which regulate the expression of genes important for DNA 
replication and mitosis (Nevins, 2001). In humans, germline mutations resulting in a 
single dysfunctional copy of RB followed by the loss of the remaining allele in the retina 
lead to the development of hereditary retinoblastoma, which usually forms bilaterally. 
While the incidence of retinoblastoma has stabilized over the last thirty years, disease 
prognosis has significantly improved with advancing cancer treatments (Seregard et. al, 
2003; Broaddus et. al, 2009). Fatality from retinoblastoma has drastically declined in 
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developed countries, leading to an increase in the number of retinoblastoma patients of 
childbearing age. However, no studies to date have examined the outcome of pregnancies 
from retinoblastoma survivors. Given that studies in mice have demonstrated the critical 
role of Rb in proper placental function (Wu et. al, 2003), we hypothesized that these 
patients might have difficulty carrying a pregnancy to term. To test this hypothesis in 
mice, we compiled and assessed litter size data from crosses between Rb+/- females and 
Rb+/+ males as well as between Rb+/+ females and Rb+/- males. However, we detected no 
significant difference in the average litter size of Rb+/- and Rb+/+ mothers, shown in 
Figure 1 (Wenzel, unpublished data). 
 
Problem Statement 
We have shown that there was no difference in pregnancy outcomes between Rb+/- and 
Rb+/+ mothers under normal conditions (Figure 1). Previous work has shown that 
inactivation of Rb and related pocket proteins by the Simian Virus 40 large T-antigen 
(SV40 T-Ag) in the mouse intestine resulted in decreased expression of genes encoding 
members of the cytochrome P450 family of enzymes (Sáenz-Robles et. al, 2007). We 
therefore hypothesized that under a persistent low level of toxin-induced stress Rb+/- 
mothers would have less successful pregnancies due to compromised Cyp induction. To 
test this hypothesis, we continuously administered the synthetic gluccocorticoid 
dexamethasone to pregnant Rb+/- and Rb+/+ females in their drinking water starting from 
10.5 days post-coitus and assessed the viability of their fetuses at E17.5 and post-natal 
day 0 (P0). Dexamethasone is an anti-inflammatory and a known inducer of several Cyp 
family genes (Tomilson et. al, 1997). Under these conditions, we found that the 
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percentage of fetal lethality was significantly higher in Rb+/- mothers than in Rb+/+ 
mothers. Interestingly, we did not detect a difference in the rate of lethality between Rb+/- 
and Rb+/+ fetuses from Rb+/- mothers, suggesting that fetal viability is critically dependent 
on maternal Rb function. 
The liver is the major organ responsible for the detoxification of xenobiotics and 
endogenous substances. Detoxification occurs in two phases, with phase I mediated by 
the cytochrome P450 family of enzymes (CYPs) that catalyze the hydroxylation and 
demethylation of compounds destined for elimination from the body (Lindros, 1997). 
Known inducers of CYP expression and activity include caffeine, alcohol, and cigarettes, 
all of which have been shown to increase the likelihood of spontaneous abortions 
(Higdon et. al 2006, Rasch 2003). Interestingly, a polymorphism in CYP1B1 was recently 
found to be associated with a higher risk of first trimester miscarriage (Karypidis et. al, 
2006). These findings suggest that CYP expression and activity have an important role in 
maintaining healthy pregnancies. Phase II detoxification involves enzymes such as 
uridinediphosphate-glucuronosyltransferase (UGT), glutathione S-transferase (GST), and 
sulfotransferase (SULT) that catalyze the formation of phase I products into more water-
soluble derivatives for renal elimination (Grant, 1991). Previous work has shown that 
inactivation of Rb and related pocket proteins by the Simian Virus 40 large T-antigen 
(SV40 T-Ag) in the mouse intestine resulted in decreased expression of a number of 
genes encoding enzymes that participate mostly in phase I detoxification (Sáenz-Robles 
et. al, 2007). Given that the liver is the predominant site of expression and activity of 
most CYP isoforms, using a conditional gene knockout approach in mice we asked 
whether liver-specific ablation of Rb would also result in the deregulated expression of 
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various members of the Cyp gene family. Under the same set of experimental conditions 
as the Rb+/- mouse, a mother with an ablation of one copy of Rb only in the liver has a 
significant rate of fetal lethality. However, lethality in the liver-specific deletion is not as 
high as the Rb knockout, pointing to additional tissues in which Rb may play a role 
during pregnancy. Since the Cyp genes are highly expressed in the liver, we hypothesized 
that detoxification levels may be affected. 
  
Significance 
Inactivation of RB through direct mutations of the RB gene or deregulation of other 
components in the RB tumor suppressor network has been identified in most human 
cancers (Harbour and Dean, 2007).  In this work, we propose a novel link between RB 
and CYP expression and activity that appears to be independent of RB’s role in cell cycle 
control. This link could alter the approach to treatment of retinoblastoma patients, who 
are predisposed to the development of other types of cancer including small cell lung 
carcinoma and osteosarcoma (Hawkins, 1986). Precisely how RB impacts CYP levels is 
currently not known, but one possible mechanism could be through direct regulatory 
control of CYP transcription. A decrease in the level of functional RB could potentially 
produce a decrease in CYP function, which includes metabolizing drugs used for the 
treatment of cancer. As a result, the effective dose of chemotherapeutics given to 
retinoblastoma or other cancer patients must be adjusted accordingly in an effort to 
minimize the morbidity associated with most chemotherapeutic regimens. 
A second significant contribution of this work is towards an understanding of the 
underlying genetic basis of miscarriage and other pregnancy-associated complications. 
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With advancing treatments, more children with hereditary retinoblastoma survive to 
adulthood. If these survivors choose to have children, they are more incidents of 
maternal-fetal detoxification, calling into question how functional this detoxification is. 
Also, identifying a possible compromised detoxification could lead towards prevention of 
certain miscarriages and other pregnancy disorders in retinoblastoma patients. Perhaps 
more importantly, this would represent the first of many genes that are likely involved in 
this process and that might be related to pregnancy disorders in humans. 
 
Materials and Methods: 
Albumin-cre mice 
Cre-recombinase, or cre (causes recombination), is a bacteriophage-derived enzyme that 
promotes site-specific (the 34-base-pair “lox” sequence) recombination of DNA (Sauer 
and Henderson, 1988). The tissue-specific expression of cre is achieved by linking the 
cre gene to a cell type-specific promoter.  Generation of the transgenic Albumin-cre (Alb-
cre) mice has been previously described (Magnuson and Postic, 2000; Postic et. al,., 
1999). These transgenic mice express cre specifically in the hepatocytes, and Alb-cre-
mediated deletion of different conditional alleles has been demonstrated to be nearly 
100% at 6 weeks of age (Magnuson and Postic, 2000; Postic et. al, 1999). The 
conditional Rb allele (RbLoxP) harbors two lox sequences flanking exon 19 of the gene. 
Previous work from the Knudsen Lab has shown that deletion of the RbLoxP allele was 
efficiently mediated by Alb-cre by approximately 4 weeks of age (Mayhew et. al,., 2005). 
 
Mice and genotyping 
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RbLoxP/LoxP;Alb-cre+/- mice were obtained from the Knudsen Lab. Rb+/- (Jacks et. al,. 
1992) and RbLoxP/LoxP;Alb-cre+/- mice were bred into and maintained on a pure FVB 
background. The mice were housed under standard conditions on a 12:12 hr light-dark 
cycle and controlled temperature (21 oC - 23 oC). The mice were given food and water ad 
libitum. Mice and embryos were genotyped by PCR (Rb+/-: 3’-
GCCTGAAGAACGAGATCAGCAGC-5’, 3’-GCATCTGCATCTTTATCGCAGCAG-
5’, 3’-CCCATGTTCGGTCCCTAG-5’; RbLoxP/LoxP: 5’-GGCGTGTGCCATCAATG-3’, 
5’-CTCAAGAGCTCAGACTCATGC-3’; Alb-cre: 5’-
GCGGTCTGGCAGTAAAAACTATC-3’, 5’- GTGAAACAGCATTGCTGTCACTT-
3’). Females were mated with males and then housed in groups of three or four. At day 
E10.5 of pregnancy (vaginal plug found the morning after mating is considered day 
E0.5), mice were either injected intraperitoneally (IP) with dexamethasone every other 
day or given filtered water with 0.005 mg/mL dexamethasone ad libitum until day of 
delivery. Glucose readings were taken four times throughout pregnancy of a subset of 
mice that received IP delivery of dexamethasone. 
 
Assessment of fetal viability 
Postnatal day 0 (P0) Pups were determined as alive, dead, or compromised on the basis of 
breathing and heartbeat. Pups were counted as compromised if they appeared blue and 
hypoxic, had an irregular heartbeat, or were gasping for air. A subset of pregnant females 
given oral dexamethasone was sacrificed on day E17.5 and fetal viability was observed. 
Fetuses were counted as alive if they were breathing, moving, or had a heartbeat. Dead 
embryos did not breathe, move, or have a heartbeat.  
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IP and oral delivery of dexamethasone 
Dexamethasone (Sigma) was stored at 4º C and kept out of direct light. Pregnant dams 
received IP injections of dexamethasone suspended in sterile filtered corn oil at a 
concentration of 0.05 mg/kg every other day beginning at day E10.5 until birth of pups. 
Sterile needles were used and mice were weighed just before injection to determine dose. 
Water-soluble dexamethasone (Sigma) was stored at 4º C and kept out of direct light. 
Pregnant dams were given 0.005 mg/mL dexamethasone in drinking water ad libitum 
beginning at day E10.5 until harvest at day E17.5.  
 
Real time-PCR 
The liver, kidney, intestine, and lung were removed from pregnant dams at day E17.5. 
Total RNA was isolated from tissues after homogenization in TRIzol reagent (Life 
Technologies). RNA was used to generate cDNA using Superscript III reverse 
transcriptase (Invitrogen). Real time-PCR (RT-PCR) was performed using the BioRad 
iCycler PCR machine. A 25μl final reaction volume contained 0.25μl of cDNA template, 
100 nM primers, and 1x SYBR Green Reaction Mix (BioRad). Reactions were performed 
in triplicates for each sample and relative gene expression determined by normalizing 
against GAPDH expression.  
 
Data analysis 
Chi-squared test was performed to test significance. Lethality data from Rb+/+ males 
crossed with Rb+/+ and Rb+/- females as well as data from Rb+/- males crossed with Rb+/+ 
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females was sent to the OSU Center for Biostatistics and pooled by experiment. A 
logistic regression clustering was run to generate an odds ratio for each group. 
 
Results: 
Haploinsufficiency of Rb is sufficient to negatively impact pregnancy when 
challenged with dexamethasone 
We hypothesized that Rb potentially mediates detoxification through the Cyp genes, 
which were not activated under the previous ideal environment. To induce Cyp 
expression, the anti-inflammatory steroid dexamethasone was chosen to simulate a low 
level of constant detoxification of dietary and environmental toxins. A small initial 
experiment in wild-type mice (n=6) determined the concentration of dexamethasone 
required to adversely affect but not completely terminate the pregnancy. Wild-type mice 
were also injected with only sterile filtered corn oil as a control. No lethality from corn 
oil was observed. A dose of 0.05mg/kg dexamethasone was chosen because it gave a low 
level (~10%) of lethality in the wild-type mice.  
Since dexamethasone can stimulate diabetes-like symptoms in mice (Wong et. al, 
1971), glucose readings were taken with a standard glucometer from the tail vein of a 
small subset of mice (n=3) to ensure that any negative effects observed in the Rb+/- and 
Rb+/+ females would not be due the potential hypoglycemic effects of dexamethasone. 
Glucose readings were taken before the first dose of dexamethasone at E10.5, then at 
E15.5, and finally after the pups had been delivered (E19.5-E21.5) from Rb+/- and Rb+/+ 
mice. Glucose was measured in non-pregnant Rb+/- and Rb+/+ mice as control. There was 
no significant difference in the blood glucose levels between the two genotypes. 
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 Rb+/- and Rb+/+ mothers were bred with Rb+/+ males and injected IP every other 
day with dexamethasone beginning at E10.5 (vaginal plug = E0.5). At birth, pups were 
categorized as dead, alive, or compromised. While a low level of lethality was observed 
from Rb +/+ mothers, offspring from Rb+/- mothers showed a marked increase in fetal 
lethality at birth (35/182, 19.23%) as compared to offspring from Rb+/+ mothers (7/117, 
5.98% p<0.01), suggesting a novel role for Rb in regulating fetal viability (Figure 2). 
Moreover, a significant number of Rb+/- offspring showed signs of compromise such as a 
decrease in size and oxygenation, appeared to be gasping for air (21/182, 11.54%, 
p<0.001), and died shortly after birth. These effects were not observed in offspring from 
Rb+/+ mothers. The compromised pups were included with the dead pups when 
calculating odds ratios, since this was not a truly successful pregnancy (56/182, 30.77%). 
When combined with the percentage of dead pups, the odds ratio was 6.98 (95% 
confidence interval: 3.09-15.80) with a p-value <0.001.  The odds of a pup being born 
compromised or dead are almost seven times greater from the Rb+/- mother than from the 
Rb+/+ mother, suggesting that Rb has a potential role in determining a successful 
pregnancy. 
 
Rb function in the embryonic portion of the placenta does not contribute to fetal 
lethality. 
The placenta is highly vascularized and is critical for the exchange of waste and nutrients 
between mother and fetus. Although the placenta is often thought to be part of the 
mother, the majority of this tissue is actually derived from the embryo, and thus reflects 
the genotype of that embryo. Previous research has shown that Rb-/- fetuses can be 
 12
rescued to birth by supplying them Rb+/+ placenta (Wu et. al, 2003). Also, complete 
placental ablation of Rb by the placenta-specific Cyp19-cre results in a large reduction in 
the surface area of the placenta and disruption of the vasculature (Wenzel et. al, 2007). 
We hypothesized that if two copies of functional Rb are required in the placenta for a 
successful pregnancy, then we would see a larger percentage of Rb+/- pups dying as 
compared to Rb+/+ pups when looking at the genotypes of embryos from Rb+/- females. 
Here we show that the loss of one allele of Rb in the embryonic portion of the placenta is 
not sufficient to determine fetal lethality, pointing to a maternal and not embryonic role 
for Rb in determining a successful pregnancy. 
The genotypes of offspring from Rb+/- mothers injected IP with dexamethasone 
were analyzed. From Rb+/- females crossed with Rb+/+ males, there is a 50% chance the 
offspring would be Rb+/-. Therefore, any one dead or compromised offspring should have 
a 50% chance of being Rb+/-. We calculated that in our breeding, each pup had a 53% of 
being heterozygous. Out of all unsuccessful pregnancies from Rb+/- mothers, 
heterozygous offspring accounted for 67.5% of dead and compromised offspring (27/40, 
p>0.05). However, there was no statistically significant difference in lethality or 
compromise between Rb+/- and Rb+/+ offspring, suggesting that the loss of one Rb allele 
in the embryonic portion of the placenta does not contribute to fetal lethality (Figure 3).  
 
Hepatic and intestinal Cyp expression is not affected by maternal loss of Rb function 
The liver is one of the essential organs for detoxification. We collected maternal livers 
after delivery treated with dexamethasone and isolated RNA from the livers for analysis 
of the level of Cyp expression by RT-PCR. We hypothesized that any change in Cyp 
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expression would reflect a difference in the metabolic capacity of the liver of Rb+/- and 
Rb+/+ mothers. We measured the expression levels of Cyp1a1, 3a25, and 2d10, which 
were previously shown to be down-regulated with the ablation of Rb function in the 
mouse intestine (Sáenz-Robles et. al, 2007). Dexamethasone is also a known inducer of 
Cyp genes including Cyp3a25, the mouse homologue of CYP3a4 associated with 
detoxifying prescription drugs (Grant, 1991). The expression of Gstt1 gene encoding a 
phase II enzyme was also analyzed.  
RNA was isolated from maternal intestines in an effort to reproduce the result of 
Cyp down-regulation observed with the T-Ag-mediated intestinal inactivation of Rb. 
Failing to reproduce the Cyp down-regulation previously observed in the intestine could 
be due to different methods of Rb inactivation. Simian virus 40 Large T Antigen, or 
SV40TAg, inactivates the protein by binding Rb and related proteins p107, p130, and the 
tumor suppressor p53 (Ali and DeCaprio, 2001). Since Rb is a suppressor, the E2F 
binding target of Rb is free to stimulate transcription much like in the Rb knockout 
mouse. Still, other proteins in the Rb family are affected which are present in the 
knockout. Furthermore, the previous down-regulation of the Cyp genes was observed 
with a complete inactivation of Rb unlike in the heterozygous Rb+/- mouse.  
Although the Cyp genes were up-regulated by the dexamethasone compared to 
mice without drug, there was no significant difference between expression levels of 
detoxification enzymes in Rb+/- and Rb+/+ mothers in the liver or the intestine (Figure 4). 
It is possible that the Cyp detoxification genes do not play a role in the fetal lethality 
observed. However, there are numerous Cyp genes as well as multiple genes involved in 
the phase II detoxification pathway which were not analyzed.  
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 Average Cyp and Gstt1 levels were similar between genotypes. However, there 
were large variations between maternal Cyp expression in both wild-type and Rb+/-  
animals. Deviation from the average expression levels from wild-type mice were graphed 
against overall percentage of unsuccessful pregnancy, the combination of compromise 
and lethality, in each Rb+/- mouse. Since lethality and compromise varied between 
mother, it was hypothesized that the lower the Cyp expression, the higher the percentage 
of unsuccessful pregnancy in each litter would be. There was no statistically significant 
correlation between Cyp expression change and pregnancy success (Figure 5). 
Interestingly, the larger the deviation in Cyp genes 1a1 and 3a25, whether up or down-
regulated, from the wild-type average expression of these genes (change of 0) in the 
heterozygous mouse, the less fetal lethality was observed in the litter.  
  
Oral dexamethasone significantly negatively impacts pregnancy in Rb+/- mothers  
To assess whether the differences seen in fetal lethality were due to the dexamethasone 
and not due to mechanical injury to the fetus or placenta, oral dexamethasone was chosen 
as a preferred method of challenging pregnant dams with toxic stress. The 
dexamethasone used had an added phosphate group which made the compound more 
water-soluble. A second dose experiment was performed in Rb+/- mice with four separate 
doses to determine the concentration of water-soluble dexamethasone needed to confer 
approximately the same level of fetal lethality observed in the IP injections.  
Rb+/- and Rb+/+ mothers were crossed with wild-type males and separated and 
housed in groups of five after plugging. At day E10.5 of pregnancy, the mice were 
administered dexamethasone through drinking water ad libitum in a dark water bottle to 
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ensure the dexamethasone would not be degraded by exposure to light. The mice were 
allowed to progress to delivery, and fetal lethality was observed. At birth, offspring were 
determined as either dead or alive on the basis of movement, breathing, and heartbeat 
after decapitation. No compromised offspring were observed.  
 Rb+/- mothers again gave birth to a significantly higher number of dead pups than 
did Rb+/+, confirming previous results and validating oral dexamethasone as a practical 
delivery method. There was an overall increase in lethality compared to the injections. 
However, the relative differences between the two genotypes were similar to results 
obtained from IP injections, with wild-type mothers having a lower lethality (17/124, 
13.71%) than Rb+/- mothers (68/128, 53.13%, Figure 6). The odds ratio was very close to 
our previous results, being that a pup born from a Rb+/-  mother is 7.13 times more likely 
to be dead than a pup born from a Rb+/+mother (95% confidence interval: 2.10-24.28, p-
value = 0.002). These results suggest that Rb plays a significant role in determining a 
successful pregnancy. 
 
Fetal lethality is maternally derived 
To further the hypothesis that fetal lethality correlated with maternal haploinsufficiency 
of Rb, three breedings of mice were used: Rb+/+ males were crossed with Rb+/+ and Rb+/- 
females as well as Rb+/- males crossed with Rb+/+ females. Mothers from all three groups 
were administered oral dexamethasone in drinking water beginning at day E10.5. At day 
E17.5, the mice were harvested and fetal lethality was observed to ensure that any 
differences would not be because of difficulty during or just after delivery. 
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 Consistent with previous experiments, Rb+/- mothers had a significantly higher 
percent of fetal lethality than the Rb+/+ mothers (Figure 7). Compared with previous data 
collected upon delivery of offspring, there was an overall decrease in lethality. This 
suggests that some of the previously observed deaths among offspring might either be 
due to factors other than the dexamethasone, such as maternal neglect at birth or 
difficulty during delivery, or that some deaths occur late in pregnancy. Harvesting the 
mothers instead of collecting the pups at delivery demonstrated that embryonic lethality 
occurred at all stages of pregnancy. Dead embryos ranged from small reabsorptions to 
fully developed embryos the same size as live pups. Also, there were no instances in 
which all deaths were from a single side of the uterine horn, suggesting that lethality is 
not due to a failure within a single ovary. 
 Offspring from both Rb+/+ males crossed with Rb+/+ females and from an Rb+/- 
male bred with an Rb+/+ female had similar low levels of lethality (12/129, 9.3% and 
7/100, 7% respectively). Under the same experimental conditions, an Rb+/- female 
crossed with a Rb+/+ male gave birth to a significantly higher number of dead embryos 
(49/127, 38.6%), furthering the hypothesis that it is the maternal role of Rb which 
determines a successful pregnancy. It is 6.3 times more likely that a dead pup will be 
born from an Rb+/- mother compared to an Rb+/+  mother (95% confidence interval: 2.67-
14.05, p<0.001). This odds ratio is similar to previous results, although lower because of 
observing lethality early in the pregnancy. 
 
Rb function is essential in the maternal liver for a successful pregnancy  
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Using an Albumin-cre transgene, Rb was deleted in the maternal liver. Three subsets of 
mice were used, Rb+/+-cre, Rb+/LoxP-cre and RbLoxP/LoxP-cre. Rb+/+-cre was used as a wild-
type control for potential Albumin-cre induced toxicity. All three genotypes were bred 
with Rb+/+ males and separated after becoming pregnant. At day 10 of pregnancy, mice 
were given oral dexamethasone through drinking water, and harvested at E17.5 to 
observe fetal viability. Pups were determined to be alive based of movement, breathing, 
and heartbeat at decapitation. No compromised pups were observed.  
Rb+/+-cre mothers crossed with Rb+/+males had a similar level of lethality 
(15/146, 10.3%, Figure 8) compared to lethality from wild-type mothers observed in 
previous experiments (12/129, 9.3%), demonstrating that any observed toxicity in other 
subsets of mice was not due to the Albumin-cre. A significant level of fetal lethality was 
observed in offspring from Rb+/LoxP-cre mothers, essentially heterozygous for Rb only in 
the liver (43/120, 35.8%, p<0.005). If Rb is to play a crucial role during pregnancy, it 
must be in the liver. The lethality was slightly less than previously observed from the 
Rb+/- mothers, (49/127, 38.6%) pointing to possible additional tissues in which Rb is 
essential during pregnancy. 
Surprisingly, the RbLoxP/LoxP-cre subset of mice did not have a higher percentage 
of lethality than did the Rb+/LoxP-cre mothers. The percentage of unsuccessful pregnancy 
was in between that of the Rb+/+-cre  and Rb+/LoxP-cre mice (11/49, 22.5%). It is possible 
this difference is because of the small sample size (n=5). If Rb were mediating a 
detoxification pathway in the liver affected by the loss of one allele, potentially a 
complete ablation of Rb could force a shift to an alternative mechanism. However, until 
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the mechanism by which Rb affects pregnancy is discovered, the answer remains 
uncertain. 
 
Discussion: 
Conclusion: 
The Rb gene was the first tumor suppressor identified, but it is still not completely 
understood. New data has shown that Rb potentially mediates such diverse pathways as 
detoxification (Sáenz-Robles et. al, 2007). Here we demonstrate the first known role of 
Rb during pregnancy. We show that the loss of one copy of Rb is sufficient to negatively 
affect pregnancy under the administration of the gluccocorticoid dexamethasone. 
However, it is possible that there are many potential toxins that could affect the 
pregnancy of someone with a mutation in Rb. 
Interestingly, it is maternal Rb function and not the fetal function that causes the 
observed lethality. It is only when the mother has an ablation of Rb that significant fetal 
lethality is observed. Also, the genotype of the offspring does not correlate with an 
unsuccessful pregnancy. Furthermore, we pinpoint the maternal liver as one of the organs 
in which Rb plays a role during pregnancy. Although the liver is an essential organ for 
detoxification, we found no statistically significant difference between the expression 
levels of those genes responsible for detoxification. 
 
Future Directions: 
This project has answered many questions about the link between Rb and pregnancy 
while leaving others unanswered. The next project will determine if specific mutations in 
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the gene observed in retinoblastoma are sufficient to impact the viability of the 
pregnancy. Four common mutations will be chosen that mimic changes in the Rb gene in 
human retinoblastoma, and the experiment will be repeated. If fetal lethality is still 
observed from pregnant dams with the mutations, not only will Rb be linked to pregnancy 
and the disease retinoblastoma, but also potentially to other human cancers. Rb is mutated 
in approximately 30% of all human cancers, and changes in the Rb pathway have been 
discovered in many more (Harbour and Dean, 2007). Furthermore, differences in the 
lethality between the distinct mutations might elucidate the pathway by which Rb affects 
pregnancy. 
The largest limitation of this project was the inability to discover which genes are 
affected during the observed lethality. This could either be because we only examined a 
small subset of the Cyp genes, or that they are not involved. A microarray would be the 
most efficient way to examine a large number of genes at one time, and document up or 
down regulation. Finally, discovering the complete pathway by which this fetal lethality 
occurs will be a major project in the near future. 
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a) 
 Rb+/+ ♂   x   Rb+/- ♀ Rb+/- ♂   x    Rb+/+ ♀ Rb+/- ♂   x   Rb+/-  ♀ 
       
 H W H W H W 
Offspring 241 (230) 219 (240) 91 (87.5) 84 (87.5) 671 (692) 367 (346) 
       
Ratio  1: 1.100457 (1:1) 1: 1.08333 (1:1) 1: 1.828338 (1:2) 
 
 
 b) 
 Rb+/+ ♂   x   Rb+/- ♀ Rb+/- ♂   x    Rb+/+ ♀ Rb+/- ♂   x   Rb+/-  ♀ 
Total # 
 
535 144 1120 
Average 
 
7.039474 8.470588 6.256983 
 
Figure 1: a) Schematic of compiled data from null maternal Rb, null paternal Rb, and 
intercross. There is no significant difference between the observed and expected 
frequency of passing the mutation.  Observed (expected). 
b) Average litter size from compiled data. There is no statistical significance between the 
crosses. The reduced litter size between the Rb+/- x Rb+/- mice can be accounted for by the 
lethality of Rb mutants at embryonic day 15. 
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IP injections of dexamethasone, birth  
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b) 
 
 Rb+/+ ♂   x    Rb+/+ ♀ Rb+/+ ♂   x   Rb+/- ♀ 
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Total 
7* (16.4) 
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117 
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21 (12.8) 
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Figure 2: a) Graph of percentages viable offspring, fetal lethality, and compromise vs. 
genotype of mothers injected with dexamethasone. Rb+/-  mothers are represented with 
the red bar, while Rb+/+ mothers are represented in black. There is a significant increase 
in the percent of fetal lethality from heterozygous mothers. 
b) Table with offspring death and compromise from the two maternal genotypes. There 
were 35/182 dead offspring from Rb+/-  mothers, as compared to 7/117 dead from Rb+/+ 
mothers (p<0.01). Expected values are in italics. * p<0.01.  #p<0.001. 
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b) 
 
   Rb+/+ offspring Rb+/- offspring 
 
Alive 
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7 (11.7) 
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Figure 3: a) Graph of percentages of live, dead, and compromised births from Rb+/-  
mothers categorized by genotype of offspring. There is no statistical significance between 
the genotypes. 
b) Table with offspring death and compromise from heterozygous mothers. There were 
13/61 unsuccessful pregnancies that were  Rb+/+ compared to 27/71 that were Rb+/- . This 
was not statistically significant. 
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Figure 4: Schematic of the average Cyp and Gstt1 levels in the livers of Rb+/+ (wt liver) 
and Rb+/-  (Rb het liver) mothers. Expression levels were normalized to wild-type control. 
There is no significant difference in the expression levels, indicating that Rb does not 
function as a mediator for these genes in the liver. 
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Figure 5: a) Cyp1a1 and 3a25 expression levels were subtracted from the average Rb+/+ 
fold expression to generate fold deviation, which is plotted against percent of lethality 
and compromise in the litter. The greater the deviation, the less lethality and compromise 
observed in the litter. 
b) Expression of Cyp1a1, 2d10, and 3a25 were averaged and subtracted from the 
average Rb+/+ Cyp expression to generate fold deviation, plotted against lethality and 
compromise of the litter. The same trend is observed, though not significant.
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b) 
 
 Rb+/+ ♂   x   Rb+/- ♀ Rb+/+ ♂   x    Rb+/+ ♀ 
 
Alive 60 107 
Dead 
 
Total 
68 (43.2) 
 
128 
17* (41.8) 
 
124 
 
 
Figure 6: a) Graph of percentages viable offspring and fetal lethality vs. genotype of 
mothers under administration of oral dexamethasone. Rb+/-  mothers are represented with 
the red bar, while Rb+/+ mothers are represented in black. This confirmed previous results 
as well as using oral dexamethasone as a delivery method. 
b) Table with offspring death and compromise from the two maternal genotypes. There 
were 68/128 dead offspring from Rb+/-  mothers, as compared to 17/124 dead from Rb+/+. 
Expected values are in italics. * p<0.01. 
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Group 1 Group 2 Odds Ratio 95% Confidence 
Interval 
p-value 
Rb+/+ ♂ x Rb+/+ ♀* Rb+/+ ♂ x Rb+/- ♀  
6.13 
 
2.67-14.05 
 
<0.001 
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4.20-16.61 
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Figure 7: Graph of percentages viable offspring and fetal lethality vs. genotype of fathers 
and mothers under administration of oral dexamethasone. Rb+/-  fathers crossed with 
Rb+/+ mothers are represented with the grey bar (7% lethality), Rb+/+ fathers crossed with 
Rb+/+  mothers are represented in black (9.3% lethality), and Rb+/+ fathers crossed with 
Rb+/-   mothers are in red (38.6% lethality).  
b) Table with offspring death and compromise from the three possible crosses.  
c) Table summarizing the pairwise comparisons using logistic regression with clustering 
on litter.  The odds of a pup being born dead is 6 times greater for Rb+/+ ♂ x Rb+/- 
♀compared to Rb+/+ ♂ x Rb+/- ♀ (p<0.001) and the odds of dying is over 8 times greater 
in the Rb+/+ ♂ x Rb+/- ♀ compared to the Rb+/- ♂ x Rb+/+ ♀. *Reference group for odds 
ratio. 
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Figure 8:  Schematic of percentage of successful pregnancy and fetal lethality under 
administration of oral dexamethasone. Rb+/+; Alb-cre mothers are represented in black, 
RbLoxP/+; Alb-cre in red, and RbLoxP/LoxP; Alb-cre in grey. 
b) Table with offspring death and compromise from the three possible crosses. A much 
higher percent of deaths came from the RbLoxP/+; Alb-cre group than did the Rb+/+; Alb-cre 
(35.8% vs. 10.9%* p<0.01). The RbLoxP/LoxP-Cre group had a lower lethality than the 
RbLoxP/+; Alb-cre, but twice that of the Rb+/+Alb-cre. (22.4%).  
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